Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD

Published: 4Feb2021

TORONTO, Feb. 4, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement...

Major European grant backs McGill research on rare condition

Published: 27Jan2021

The European Joint Programme on Rare Diseases (EJP RD) has granted 1.6 million euros in support of an international research collaboration specific to the ultra-rare genetic disease, Schinzel...

Four McGill projects receive SSHRC Partnership Engage Grants

Published: 28Jan2021

SSHRC invests over $80k in new McGill research projects through the Partnership Engage Grants competition, two of which are directly related to COVID-19 research....

Kristina Öhrvall promoted to Assistant Vice-Principal, Research Development

Published: 9Nov2020

Martha Crago, Vice-Principal, Research and Innovation, announced today that Kristina Öhrvall has been promoted to Assistant Vice-Principal, Research Development, for a five-year term.


Back to top